ZA989786B - Method of reducing craving in mammals - Google Patents
Method of reducing craving in mammalsInfo
- Publication number
- ZA989786B ZA989786B ZA989786A ZA989786A ZA989786B ZA 989786 B ZA989786 B ZA 989786B ZA 989786 A ZA989786 A ZA 989786A ZA 989786 A ZA989786 A ZA 989786A ZA 989786 B ZA989786 B ZA 989786B
- Authority
- ZA
- South Africa
- Prior art keywords
- mammals
- reducing craving
- craving
- reducing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95921397A | 1997-10-28 | 1997-10-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA989786B true ZA989786B (en) | 1999-04-28 |
Family
ID=25501785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA989786A ZA989786B (en) | 1997-10-28 | 1998-10-27 | Method of reducing craving in mammals |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1043980A2 (xx) |
JP (1) | JP2001520989A (xx) |
KR (1) | KR20010031470A (xx) |
CN (1) | CN1283116A (xx) |
AR (1) | AR015984A1 (xx) |
AU (1) | AU1110099A (xx) |
BR (1) | BR9814830A (xx) |
CA (1) | CA2308453A1 (xx) |
CO (1) | CO4970824A1 (xx) |
HU (1) | HUP0100115A2 (xx) |
IL (1) | IL135659A0 (xx) |
NO (1) | NO20002149L (xx) |
PE (1) | PE122299A1 (xx) |
SK (1) | SK5812000A3 (xx) |
WO (1) | WO1999021540A2 (xx) |
ZA (1) | ZA989786B (xx) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6410527B1 (en) * | 1998-03-02 | 2002-06-25 | Schering Corporation | Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism |
US6890951B2 (en) | 1998-08-05 | 2005-05-10 | Brookhaven Science Associates Llc | Treatment of addiction and addiction-related behavior |
US6541520B1 (en) | 1998-08-05 | 2003-04-01 | Brookhaven Science Associates | Treatment of addiction and addiction-related behavior |
IL137937A0 (en) * | 1999-08-27 | 2001-10-31 | Pfizer Prod Inc | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
US6395783B1 (en) | 2000-10-23 | 2002-05-28 | Brookhaven Science Associates, Llc | Treatment of PCP addiction and PCP addiction-related behavior |
US6462084B1 (en) | 2001-05-14 | 2002-10-08 | Brookhaven Science Associates, Llc | Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG |
US20030087814A1 (en) | 2001-11-05 | 2003-05-08 | Seth Lederman | Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism |
EP2611440B1 (en) | 2010-09-01 | 2017-02-01 | Tonix Pharmaceuticals, Inc. | Treatment for cocaine addiction |
ES2914043T3 (es) | 2012-07-12 | 2022-06-07 | Emalex Biosciences Inc | Benzazepinas condensadas para el tratamiento del síndrome de tourette |
SI3057595T1 (sl) | 2013-10-18 | 2020-09-30 | Emalex Biosciences, Inc. | Spojeni benzazepini za zdravljenje jecljanja |
CN110327350B (zh) * | 2019-07-11 | 2021-02-23 | 温州医科大学 | 多巴胺d1受体拮抗剂sch39166在作为制备治疗眼部病理性血管新生药物的应用 |
CN110833621A (zh) * | 2019-12-06 | 2020-02-25 | 中国医科大学 | 多巴胺受体1拮抗剂在制备治疗对氯胺酮致小鼠类精神分裂症药物上的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5607967A (en) * | 1994-10-27 | 1997-03-04 | Merck & Co., Inc. | Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid |
JP2000513337A (ja) * | 1996-06-06 | 2000-10-10 | エルゴ・リサーチ・コーポレイション | ドーパミン及びセロトニンアゴニストによる脂質及びグルコース代謝障害の治療 |
-
1998
- 1998-10-26 CO CO98062495A patent/CO4970824A1/es unknown
- 1998-10-26 WO PCT/US1998/022255 patent/WO1999021540A2/en not_active Application Discontinuation
- 1998-10-26 IL IL13565998A patent/IL135659A0/xx unknown
- 1998-10-26 CN CN98812730A patent/CN1283116A/zh active Pending
- 1998-10-26 KR KR1020007004505A patent/KR20010031470A/ko not_active Application Discontinuation
- 1998-10-26 SK SK581-2000A patent/SK5812000A3/sk unknown
- 1998-10-26 BR BR9814830-3A patent/BR9814830A/pt not_active Application Discontinuation
- 1998-10-26 HU HU0100115A patent/HUP0100115A2/hu unknown
- 1998-10-26 CA CA002308453A patent/CA2308453A1/en not_active Abandoned
- 1998-10-26 AU AU11100/99A patent/AU1110099A/en not_active Abandoned
- 1998-10-26 JP JP2000517699A patent/JP2001520989A/ja not_active Withdrawn
- 1998-10-26 EP EP98953826A patent/EP1043980A2/en not_active Withdrawn
- 1998-10-27 ZA ZA989786A patent/ZA989786B/xx unknown
- 1998-10-27 AR ARP980105373A patent/AR015984A1/es unknown
- 1998-10-27 PE PE1998001010A patent/PE122299A1/es not_active Application Discontinuation
-
2000
- 2000-04-27 NO NO20002149A patent/NO20002149L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20002149L (no) | 2000-06-26 |
WO1999021540B1 (en) | 1999-10-28 |
CO4970824A1 (es) | 2000-11-07 |
JP2001520989A (ja) | 2001-11-06 |
AR015984A1 (es) | 2001-05-30 |
CN1283116A (zh) | 2001-02-07 |
IL135659A0 (en) | 2001-05-20 |
WO1999021540A3 (en) | 1999-09-02 |
PE122299A1 (es) | 1999-12-04 |
EP1043980A2 (en) | 2000-10-18 |
KR20010031470A (ko) | 2001-04-16 |
NO20002149D0 (no) | 2000-04-27 |
CA2308453A1 (en) | 1999-05-06 |
WO1999021540A2 (en) | 1999-05-06 |
SK5812000A3 (en) | 2000-12-11 |
HUP0100115A2 (hu) | 2001-06-28 |
BR9814830A (pt) | 2000-10-03 |
AU1110099A (en) | 1999-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL127912A0 (en) | Method of activating dendritic cells | |
IL125829A0 (en) | Method of sharing cryptokey | |
GB2311695B (en) | Method of and telephone with call-reminding and auto-dialing | |
PL332741A1 (en) | Battery and method of making same | |
EP0767524A3 (en) | Method and structure for balancing energy sources | |
EP0720228A3 (en) | Semiconductor connection structure and method | |
ZA989400B (en) | Method and composition | |
GB2298713B (en) | Method and composition | |
EP0716478A3 (en) | Structure and method of electrical connection | |
ZA989786B (en) | Method of reducing craving in mammals | |
ZA989398B (en) | Method and composition (l) | |
PL326102A1 (en) | Decorative laminate and method of making same | |
GB2323745B (en) | System and method relating to telecommunications | |
EP0707343A3 (en) | Structure and method for connecting integrated circuits | |
GB2332181B (en) | Method of synchronizing first and second steering arrangements | |
GB9626906D0 (en) | Method of blow-moulding | |
PL339770A1 (en) | Stator and method of making same | |
GB9621533D0 (en) | Composition and method | |
PL334918A1 (en) | Stator and method of making same | |
GB2311218B (en) | Improvements in and relating to baths | |
GB9726186D0 (en) | Method of moulding | |
PL314704A1 (en) | Method of obtaining pure cadmium | |
IL117256A0 (en) | Method of manufacturing an intermediate of kvass | |
GB9626046D0 (en) | Methods of manufacturing engines | |
PL322291A1 (en) | Structural component and method of making same |